The US Food and Drug Administration: A dysfunctional agency in need of major reforms

被引：2
|
作者：
Steven E. Nissen
机构：
[1] The Cleveland Clinic,Department of Cardiovascular Medicine
来源：
Current Cardiology Reports | 2007年 / 9卷 / 3期
关键词：
D O I：
10.1007/BF02938344
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 169
页数：2
相关论文
共 50 条
  • [41] US Food and Drug Administration Clinical Investigator Inspections
    Buchmeier, Andrea D.
    SEMINARS IN ONCOLOGY NURSING, 2020, 36 (02)
  • [42] The US Food and Drug Administration and the Future of Cardiovascular Medicine
    Fiuzat, Mona
    Califf, Robert M.
    JAMA CARDIOLOGY, 2016, 1 (08) : 950 - 952
  • [43] US Food and Drug Administration approval of esketamine and brexanolone
    Cristea, Ioana A.
    Naudet, Florian
    LANCET PSYCHIATRY, 2019, 6 (12): : 975 - 977
  • [44] The History of Dermatology and Dermatologists at the US Food and Drug Administration
    Burrows, Vanessa L.
    Luke, Markham C.
    DERMATOLOGIC CLINICS, 2022, 40 (03) : 237 - 248
  • [45] An Analysis of Regulatory Timing and Outcomes for New Drug Applications Submitted to Swissmedic: Comparison With the US Food and Drug Administration and the European Medicines Agency
    Petra Dörr
    Alison Wadworth
    Tina Wang
    Neil McAuslane
    Lawrence Liberti
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 734 - 742
  • [46] What about the role of the US food and drug administration?
    Bigby, BG
    Bigby, TD
    CHEST, 2002, 122 (05) : 1869 - 1870
  • [47] Recalls of foods and cosmetics by the US Food and Drug Administration
    Venugopal, R
    Tollefson, L
    Hyman, FN
    Timbo, B
    Joyce, RE
    Klontz, KC
    JOURNAL OF FOOD PROTECTION, 1996, 59 (08) : 876 - 880
  • [48] Computational Toxicology Approaches at the US Food and Drug Administration
    Yang, Chihae
    Valerio, Luis G., Jr.
    Arvidson, Kirk B.
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2009, 37 (05): : 523 - 531
  • [49] Regulatory science within US Food and Drug Administration
    Patwardhan, Dinesh
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [50] The US Food and Drug Administration and probiotics: Regulatory categorization
    Degnan, Frederick H.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 : S133 - S136
12345